Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Comment by stockman6767on Sep 11, 2020 2:11pm
212 Views
Post# 31543729

RE:RE:Thomvest plans are obvious, they will not run LMNL for years

RE:RE:Thomvest plans are obvious, they will not run LMNL for yearsGunner, I am not happy with management due their past greedy restructure at the expense of the investors they promised to support. But I do believe in the science and I too was very surprised that the expected pop on the BLA did not materialize.

I do suspect that that pop may well happen when the FDA ACCEPTS the BLA submission next week which will end the 14 day period for the FDA response to the BLA.
<< Previous
Bullboard Posts
Next >>